RecruitingNot applicableNCT03257969

Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk Factors

Studying PAPA syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospices Civils de Lyon
Intervention
The DROP program of pharmaceutical interventions(behavioral)
Enrollment
248 target
Eligibility
18 years · All sexes
Timeline
2019 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03257969 on ClinicalTrials.gov

Other trials for PAPA syndrome

Additional recruiting or active studies for the same condition.

See all trials for PAPA syndrome →

← Back to all trials